Cannabis is quickly joining turkey, pumpkin pie and cornucopia as Thanksgiving totem.
According to business intelligence firm Akerna (US:KERN), cannabis sales for the Thanksgiving holiday rose 12% year over year. The report said “Green Wednesday,” as some call the day before Thanksgiving, saw sales rise 16% from a year ago to $116.4 million.
The report said Green Wednesday and Black Friday are on track to become the second and third-highest grossing sale days for regulated cannabis in the US for 2022, outdone only by 4/20, a number representing everything weed among aficionados. From Nov. 23 through Nov. 26, the Thanksgiving holiday weekend delivered over $289 million in sales, collectively up 12.7% year over year, the research group said.
“Cannabis has become an integral element of the Thanksgiving holiday shopping tradition,” says Jessica Billingsley, Akerna CEO.
The data company also prided more granular sales information for the holiday weekend of Nov. 23 — Nov. 26.
Category sales
- Flower: 48.7%
- Cartridge/Pens: 32.3%
- Concentrates: 11.6%
- Infused Edibles: 5.8%
- Other: 1.6%
Purchaser demographics – gender
- 60.4% men
- 39.6% women
Purchaser demographics – age
- Under 30 years old: 26.6%
- 30-40 years old: 31%
- 40-50 years old: 21.3%
- 50-60 years old: 11.8%
- Over 60 years old: 9.3%
Average order total (average dollar spend per purchase)
- Medical: $111.77
- Recreational: $68.60
Average basket size (average number of items purchased per order)
- Medical: 3.55 items
- Recreational: 3.53 items
Akerna is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $30 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq.
“Visibility and participation in the holiday shopping season is a perfect opportunity for operators and brands looking to cement their place in the hearts and minds of their customers,” Billingsley said.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.